Actinium Pharmaceuticals (ATNM) Q4 2025 Earnings

Nov 14Confirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-0.51
-0.39
-0.28
-0.16

Details

Expected EPS
-0.18
Actual EPS
-0.16
Surprise EPS
0.02
Surprise Percent
+11.11%

Description

⁨Actinium Pharmaceuticals⁩ (⁦ATNM⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts